Department of Pathology, School of Biomedical Sciences, College of Health Sciences, Makerere University, P,O, Box 7072, Kampala, Uganda.
Infect Agent Cancer. 2010 Jun 30;5:12. doi: 10.1186/1750-9378-5-12.
B cell non Hodgkin lymphomas account for the majority of lymphomas in Uganda. The commonest is endemic Burkitt lymphoma, followed by diffuse large-B-cell lymphoma (DLBCL). There has been an increase in incidence of malignant lymphoma since the onset of the HIV/AIDS pandemic. However, the possible linkages of HHV8 and EBV to the condition of impaired immunity present in AIDS are still not yet very clearly understood.
Tumour biopsies specimens from 119 patients with B cell non Hodgkin lymphoma were classified according to the WHO classification. Immunohistochemistry was used for detection of HHV8 and in situ hybridization with Epstein Barr virus encoded RNA (EBER) for EBV. Real time and nested PCR were used for the detection of HIV.The patients from whom the 1991-2000 NHL biopsies had been taken did not have HIV serology results therefore 145 patients biopsies where serology results were available were used to describe the association of HIV with non Hodgkin lymphoma type during 2008-2009.
In this study, the majority (92%) of the Burkitt lymphomas and only 34.8% of the diffuse large B cell lymphomas were EBV positive. None of the precursor B lymphoblastic lymphomas or the mantle cell lymphomas showed EBV integration in the lymphoma cells.None of the Burkitt lymphoma biopsies had HIV by PCR. Of the 121 non Hodgkin B cell lymphoma patients with HIV test results, 19% had HIV. However, only 1(0.04%) case of Burkitt lymphoma had HIV. All the tumours were HHV8 negative.
The majority of the Burkitt lymphomas and two fifths of the diffuse large B cell lymphomas had EBV. All the tumours were HHV8 negative. Generally, the relationship of NHL and HIV was weaker than what has been reported from the developed countries. We discuss the role of these viruses in lymphomagenesis in light of current knowledge.
B 细胞非霍奇金淋巴瘤占乌干达淋巴瘤的大多数。最常见的是地方性伯基特淋巴瘤,其次是弥漫性大 B 细胞淋巴瘤(DLBCL)。自艾滋病毒/艾滋病流行以来,恶性淋巴瘤的发病率有所增加。然而,HHV8 和 EBV 与艾滋病免疫受损状况的可能联系仍不太清楚。
根据世界卫生组织分类,对 119 例 B 细胞非霍奇金淋巴瘤患者的肿瘤活检标本进行分类。免疫组织化学用于检测 HHV8,原位杂交用于检测 Epstein Barr 病毒编码的 RNA(EBER)用于 EBV。实时和巢式 PCR 用于检测 HIV。1991-2000 年 NHL 活检患者未进行 HIV 血清学检测,因此,对 145 例有血清学检测结果的活检患者进行描述,以描述 2008-2009 年期间 HIV 与非霍奇金淋巴瘤类型的关系。
在这项研究中,大多数(92%)伯基特淋巴瘤和只有 34.8%的弥漫性大 B 细胞淋巴瘤是 EBV 阳性。前体 B 淋巴母细胞淋巴瘤或套细胞淋巴瘤的淋巴瘤细胞均未显示 EBV 整合。没有伯基特淋巴瘤活检标本通过 PCR 检测到 HIV。在有 HIV 检测结果的 121 例非霍奇金 B 细胞淋巴瘤患者中,19%有 HIV。然而,只有 1(0.04%)例伯基特淋巴瘤有 HIV。所有肿瘤均为 HHV8 阴性。
大多数伯基特淋巴瘤和五分之二的弥漫性大 B 细胞淋巴瘤都有 EBV。所有肿瘤均为 HHV8 阴性。一般来说,NHL 和 HIV 的关系比从发达国家报道的要弱。我们根据现有知识讨论这些病毒在淋巴瘤发生中的作用。